CN118265540A - 产生针对猪链球菌的疫苗的方法以及所述疫苗 - Google Patents

产生针对猪链球菌的疫苗的方法以及所述疫苗 Download PDF

Info

Publication number
CN118265540A
CN118265540A CN202280076533.0A CN202280076533A CN118265540A CN 118265540 A CN118265540 A CN 118265540A CN 202280076533 A CN202280076533 A CN 202280076533A CN 118265540 A CN118265540 A CN 118265540A
Authority
CN
China
Prior art keywords
vaccine
streptococcus suis
igm protease
antigen
supernatant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280076533.0A
Other languages
English (en)
Chinese (zh)
Inventor
A·A·C·雅各布斯
R·布隆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CN118265540A publication Critical patent/CN118265540A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C12N1/066—Lysis of microorganisms by physical processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202280076533.0A 2021-11-18 2022-11-17 产生针对猪链球菌的疫苗的方法以及所述疫苗 Pending CN118265540A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21208911.4 2021-11-18
EP21208911 2021-11-18
PCT/EP2022/082177 WO2023088988A1 (en) 2021-11-18 2022-11-17 A method to produce a vaccine against streptococcus suis and the said vaccine

Publications (1)

Publication Number Publication Date
CN118265540A true CN118265540A (zh) 2024-06-28

Family

ID=78695535

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280076533.0A Pending CN118265540A (zh) 2021-11-18 2022-11-17 产生针对猪链球菌的疫苗的方法以及所述疫苗

Country Status (5)

Country Link
US (1) US20240424077A1 (cg-RX-API-DMAC7.html)
EP (1) EP4433079A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024540479A (cg-RX-API-DMAC7.html)
CN (1) CN118265540A (cg-RX-API-DMAC7.html)
WO (1) WO2023088988A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026114933A1 (en) 2024-11-27 2026-06-04 Intervet International B.V. Stable vaccine against streptococcus suis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015181856A1 (ja) 2014-05-30 2015-12-03 株式会社アーバンマテリアルズ 弦楽器用エンドピン
EP2949340A1 (en) 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
US11155585B2 (en) 2015-07-09 2021-10-26 Intervacc Ab Vaccine against S. suis infection
AU2017214441B2 (en) * 2016-02-04 2021-08-19 Genovis Ab New Streptococcal proteases

Also Published As

Publication number Publication date
US20240424077A1 (en) 2024-12-26
EP4433079A1 (en) 2024-09-25
JP2024540479A (ja) 2024-10-31
WO2023088988A1 (en) 2023-05-25

Similar Documents

Publication Publication Date Title
EP0522560B2 (en) Method and composition for the prevention of Lyme disease
Fiske et al. Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations
CN114650840A (zh) 一种针对副猪嗜血杆菌的新型疫苗
US10603371B2 (en) Attenuated Pasteurella multocida vaccines and methods of making and use thereof
JP7812328B2 (ja) ヘモフィルス・パラスイスに対する新規ワクチン
JP2022506634A (ja) 豚レンサ球菌感染防御のためのワクチン
CN116063548B (zh) 一种融合蛋白KP-Ag1及其用作肺炎克雷伯菌疫苗抗原的应用
JP2023517684A (ja) ストレプトコッカス・スイス血清型9、配列型16に対する防御のためのワクチン
US20250213669A1 (en) Attenuated bordetella bronchiseptica strains, oral vaccines containing the attenuated strains, and methods of making & use thereof
CN115838431A (zh) 一种用作肺炎克雷伯菌疫苗抗原的融合蛋白KP-Ag2及其应用
US20240424077A1 (en) A method to produce a vaccine against streptococcus suis and the said vaccine
Ibrahim et al. Preparation of combined inactivated oil Adjuvanted Pasteurella spp. and Clostridium spp. vaccine (Pneumoclost) in sheep
EP4380611A1 (en) A vaccine for protection against streptococcus suis of various serotypes
Iwanaga et al. Pili of Vibrio cholerae widely distributed in serogroup O1 strains
Gao et al. Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen
CN118388607B (zh) 一种重组a型副鸡禽杆菌hmtp蛋白、疫苗组合物及其应用
RU2822516C1 (ru) Новая вакцина против haemophilus parasuis
RU2833948C1 (ru) Новая вакцина против heamophilus parasuis
CN116621952A (zh) B型副鸡禽杆菌抗原PilA蛋白及其制备方法和应用
CN100387718C (zh) 抗蛋白酶k降解的脑膜炎奈瑟氏球菌表面蛋白
CN105505952A (zh) 猪多杀性巴氏杆菌抗原基因metQ及其重组蛋白与应用
WO2023011810A1 (en) A vaccine for protection against streptococcus suis of various serotypes
Song et al. Expression of Clostridium perfringens alpha-epsilon soluble fusion toxin gene in Escherichia coli and its immunogenicity in mice.
Quraishi Submitted to
TWI418362B (zh) 溶血性巴斯德桿菌重組外膜脂蛋白e及含此之疫苗組成物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination